Association between TH2 Cytokine Gene Polymorphisms and Risk of Bullous Pemphigoid

References

• Akatsu T, Nakamura M, Satoh M, Hiramori K. 2003. Increased mRNA expression of tumour necrosis factor-alpha and its converting enzyme in circulating leucocytes of patients with acute myocardial infarction. Clin Sci (Lond). 105:39–44.
   PubMed Web of Science ®Google Scholar
• Alvarez-Rodriguez L, Lopez-Hoyos M, Carrasco-Marin E, Mata C, Calvo-Alen J, Aurrecoechea E, Blanco R, Ruiz T, Munoz Cacho P, Villa I, et al. 2012. Analysis of the rs20541 (R130Q) polymorphism in the IL-13 gene in patients with elderly-associated chronic inflammatory diseases. Reumatol Clin. 8:321–27.
   PubMedGoogle Scholar
• Amber KT, Valdebran M, Kridin K, Grando SA. 2018. The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease. Front Med (Lausanne). 5:201.
   PubMed Web of Science ®Google Scholar
• Ameglio F, D’Auria L, Bonifati C, Ferraro C, Mastroianni A, Giacalone B. 1998. Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity. Br J Dermatol. 138:611–14.
   PubMed Web of Science ®Google Scholar
• Bao K, Reinhardt RL. 2015. The differential expression of IL-4 and IL-13 and its impact on type-2 immunity. Cytokine. 75:25–37.
   PubMed Web of Science ®Google Scholar
• Bhol KC, Rojas AI, Khan IU, Ahmed AR. 2000. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid. Cytokine. 12:1076–83.
   PubMed Web of Science ®Google Scholar
• Bieber K, Sun S, Witte M, Kasprick A, Beltsiou F, Behnen M, Laskay T, Schulze FS, Pipi E, Reichhelm N, et al. 2017. Regulatory T cells suppress inflammation and blistering in pemphigoid diseases. Front Immunol. 8:1628.
   PubMed Web of Science ®Google Scholar
• Budinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, Merk HF, Yancey K, Hertl M. 1998. Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest. 102:2082–89.
   PubMed Web of Science ®Google Scholar
• Cai F, Cui N, Ma H, Wang X, Qiao G, Liu D. 2015. Interleukin-10-1082A/G polymorphism is associated with the development of acute pancreatitis in a Chinese population. Int J Clin Exp Pathol. 8:15170–76.
   PubMed Web of Science ®Google Scholar
• Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, Ramachandran H, Yu L, Stern DA, Graves PE, Lohman IC, et al. 2006. Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J Immunol. 177:8633–42.
   PubMed Web of Science ®Google Scholar
• Caproni M, Feliciani C, Fuligni A, Salvatore E, Atani L, Bianchi B, Pour SM, Proietto G, Toto P, Coscione G, et al. 1998. Th2-like cytokine activity in dermatitis herpetiformis. Br J Dermatol. 138:242–47.
   PubMed Web of Science ®Google Scholar
• Chang YT, Lee WR, Yu CW, Liu HN, Lin MW, Huang CH, Chen CC, Lee DD, Wang WJ, Hu CH, et al. 2006a. No association of cytokine gene polymorphisms in Chinese patients with atopic dermatitis. Clin Exp Dermatol. 31:419–23.
   PubMed Web of Science ®Google Scholar
• Chang YT, Liu HN, Yu CW, Lin MW, Huang CH, Chen CC, Liu MT, Lee DD, Wang WJ, Tsai SF. 2006b. Cytokine gene polymorphisms in bullous pemphigoid in a Chinese population. Br J Dermatol. 154:79–84.
   PubMed Web of Science ®Google Scholar
• Chen JG, Cai TG, Lin LY. 2018. IL-13 polymorphisms rs 20541 and rs 1800925 in atopic dermatitis: a meta-analysis. Int J Clin Exp Med. 11:6384–96.
   Web of Science ®Google Scholar
• D’Auria L, Cordiali Fei P, Ameglio F. 1999a. Cytokines and bullous pemphigoid. Eur Cytokine Netw. 10:123–34.
   PubMed Web of Science ®Google Scholar
• D’Auria L, Mussi A, Bonifati C, Mastroianni A, Giacalone B, Ameglio F. 1999b. Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity. J Eur Acad Dermatol Venereol. 12:11–15.
   PubMed Web of Science ®Google Scholar
• D’Auria L, Pietravalle M, Mastroianni A, Ferraro C, Mussi A, Bonifati C, Giacalone B, Ameglio F. 1998. IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity. Arch Dermatol Res. 290:25–27.
   PubMed Web of Science ®Google Scholar
• de Graauw E, Sitaru C, Horn M, Borradori L, Yousefi S, Simon HU, Simon D. 2017. Evidence for a role of eosinophils in blister formation in bullous pemphigoid. Allergy. 72:1105–13.
   PubMed Web of Science ®Google Scholar
• De Pita O, Frezzolini A, Cianchini G, Ruffelli M, Teofoli P, Puddu P. 1997. T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30). Arch Dermatol Res. 289:667–70.
   PubMed Web of Science ®Google Scholar
• de Vries JE. 1998. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol. 102:165–69.
   PubMed Web of Science ®Google Scholar
• Eming R, Niedermeier A, Pfütze M, Jacobi A, Hertl M. 2007. Treating autoimmune bullous skin disorders with biologics. In: Boehncke WH, Radeke HH, editors. Biologics in general medicine. Berlin (Heidelberg): Springer; p. 69–80.
   Google Scholar
• Endo H, Iwamoto I, Fujita M, Okamoto S, Yoshida S. 1992. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid. Arch Dermatol Res. 284:312–14.
   PubMed Web of Science ®Google Scholar
• Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T, Kadono T. 2017. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int. 66:398–403.
   PubMed Web of Science ®Google Scholar
• Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL. 1996. Late complications of immune deviation therapy in a nonhuman primate. Science. 274:2054–57.
   PubMed Web of Science ®Google Scholar
• Gyan BA, Goka B, Cvetkovic JT, Kurtzhals JL, Adabayeri V, Perlmann H, Lefvert AK, Akanmori BD, Troye-Blomberg M. 2004. Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Clin Exp Immunol. 138:145–50.
   PubMed Web of Science ®Google Scholar
• Haeberle S, Wei X, Bieber K, Goletz S, Ludwig RJ, Schmidt E, Enk AH, Hadaschik EN. 2018. Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease. J Allergy Clin Immunol. 142:1831–1842.e7. doi:https://doi.org/10.1016/j.jaci.2018.04.006
   PubMed Web of Science ®Google Scholar
• Heinzmann A, Mailaparambil B, Mingirulli N, Krueger M. 2009. Association of interleukin-13/-4 and toll-like receptor 10 with preterm births. Neonatology. 96:175–81.
   PubMed Web of Science ®Google Scholar
• Holtsche MM, Goletz S, van Beek N, Zillikens D, Benoit S, Harman K, Walton S, English J, Sticherling M, Chapman A, et al. 2018. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score. Br J Dermatol. 179:918–24.
   PubMed Web of Science ®Google Scholar
• Hong SJ, Lee SY, Kim HB, Kim JH, Kim BS, Choi SO, Lee SG, Shin ES, Hong TJ. 2005. IL-5 and thromboxane A2 receptor gene polymorphisms are associated with decreased pulmonary function in Korean children with atopic asthma. J Allergy Clin Immunol. 115:758–63.
   PubMed Web of Science ®Google Scholar
• Inaoki M, Takehara K. 1998. Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid. J Dermatol Sci. 16:152–57.
   PubMed Web of Science ®Google Scholar
• Jin P, Panelli MC, Marincola FM, Wang E. 2004. Cytokine polymorphism and its possible impact on cancer. Immunol Res. 30:181–90.
   PubMed Web of Science ®Google Scholar
• Li J, Lin LH, Wang J, Peng X, Dai HR, Xiao H, Li F, Wang YP, Yang ZJ, Li L. 2014. Interleukin-4 and interleukin-13 pathway genetics affect disease susceptibility, serum immunoglobulin E levels, and gene expression in asthma. Ann Allergy Asthma Immunol. 113:173–179.e171.
   PubMed Web of Science ®Google Scholar
• Liu P, Song J, Su H, Li L, Lu N, Yang R, Peng Z. 2013. IL-10 gene polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. PLoS One. 8:e69547.
   PubMedGoogle Scholar
• Liu Y, Li L, Xia Y. 2017. BP180 is critical in the autoimmunity of bullous pemphigoid. Front Immunol. 8:1752.
   PubMed Web of Science ®Google Scholar
• Liu Z. 2003. Immunopathology of bullous pemphigoid, an autoimmune and inflammatory skin blistering disease. Keio J Med. 52:128–33.
   PubMedGoogle Scholar
• Lobo Gatti L, Zambaldi Tunes M, de Labio RW, Silva LC, de Arruda Cardoso Smith M, Marques Payao SL. 2005. Interleukin-6 polymorphism and Helicobacter pylori infection in Brazilian adult patients with chronic gastritis. Clin Exp Med. 5:112–16.
   PubMed Web of Science ®Google Scholar
• Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, Komorowski L, Luo J, Cabral-Marques O, Hammers CM, et al. 2017. Mechanisms of Autoantibody-Induced Pathology. Front Immunol. 8:603.
   PubMed Web of Science ®Google Scholar
• Moravvej H, Tabatabaei-Panah PS, Ebrahimi E, Esmaeili N, Ghaderian SMH, Ludwig RJ, Akbarzadeh R. 2018. TNF-alpha −308G/A gene polymorphism in bullous pemphigoid and alopecia areata. Hum Antibodies. 26:201–07.
   PubMedGoogle Scholar
• Nakashima H, Fujimoto M. 2009. Expression of cytokines and chemokines in bullous pemphigoid. Expert Rev Dermatol. 321–27. doi:https://doi.org/10.1586/edm.09.23
   Google Scholar
• Novak N, Kruse S, Kraft S, Geiger E, Kluken H, Fimmers R, Deichmann KA, Bieber T. 2002. Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol. 119:870–75.
   PubMed Web of Science ®Google Scholar
• Plataki MN, Zervou MI, Samonis G, Daraki V, Goulielmos GN, Kofteridis DP. 2018. Association of the Interleukin-6 rs1800795 polymorphism with type 2 diabetes mellitus in the population of the Island of Crete, Greece. Genet Test Mol Biomarkers. 22:448–52.
   PubMed Web of Science ®Google Scholar
• Samavedam UK, Kalies K, Scheller J, Sadeghi H, Gupta Y, Jonkman MF, Schmidt E, Westermann J, Zillikens D, Rose-John S, et al. 2013. Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction. J Autoimmun. 40:74–85.
   PubMed Web of Science ®Google Scholar
• Sasaoka T, Ujiie H, Nishie W, Iwata H, Ishikawa M, Higashino H, Natsuga K, Shinkuma S, Shimizu H. 2018. Intravenous IgG reduces pathogenic autoantibodies, Serum IL-6 levels, and disease severity in experimental bullous pemphigoid models. J Invest Dermatol. 138:1260–67.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Zillikens D. 2013. Pemphigoid diseases. Lancet. 381:320–32.
   PubMed Web of Science ®Google Scholar
• Smolkova B, Tulinska J, Palkovicova Murinova L, Buocikova V, Liskova A, Rausova K, Kuricova M, Patayova H, Sustrova M, Neubauerova Svorcova E, et al. 2017. Impact of interleukin 13 (IL13) genetic polymorphism Arg130Gln on total serum immunoglobulin (IgE) levels and interferon (IFN)-gamma gene expression. Clin Exp Immunol. 188:45–52.
   PubMed Web of Science ®Google Scholar
• Tabatabaei-Panah PS, Moravvej H, Sadaf Z, Babaei H, Geranmayeh M, Hajmanouchehri S, Karimi A, Sajjadi F, Arghand F, Ludwig RJ, et al. 2019. Proinflammatory cytokine gene polymorphisms in bullous pemphigoid. Front Immunol. 10:636.
   PubMed Web of Science ®Google Scholar
• Tavasolian F, Abdollahi E, Samadi M. 2014. Association of the IL4R single-nucleotide polymorphism I50V with recurrent spontaneous abortion (RSA). J Assist Reprod Genet. 31:851–56.
   PubMed Web of Science ®Google Scholar
• Teraki Y, Hotta T, Shiohara T. 2001. Skin-homing interleukin-4 and −13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells. J Invest Dermatol. 117:1097–102.
   PubMed Web of Science ®Google Scholar
• Tian G, Li JL, Wang DG, Zhou D. 2014. Targeting IL-10 in auto-immune diseases. Cell Biochem Biophys. 70:37–49.
   PubMed Web of Science ®Google Scholar
• Tu Y, Fan G, Zeng T, Cai X, Kong W. 2017. Association between polymorphism within interleukin related genes and Graves’ disease: a meta-analysis of 22 case-control studies. Oncotarget. 8:98993–9002.
   PubMedGoogle Scholar
• Vandenbroeck K, Goris A. 2003. Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy? Trends Pharmacol Sci. 24:284–89.
   PubMed Web of Science ®Google Scholar
• Williams HC, Wojnarowska F, Kirtschig G, Mason J, Godec TR, Schmidt E, Chalmers JR, Childs M, Walton S, Harman K, et al. 2017. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet. 389:1630–38.
   PubMed Web of Science ®Google Scholar
• Yang HT, Wang SL, Yan LJ, Qian P, Duan HY. 2015. Association of interleukin gene polymorphisms with the risk of coronary artery disease. Genet Mol Res. 14:12489–96.
   PubMed Web of Science ®Google Scholar
• Zhu W, Liu N, Zhao Y, Jia H, Cui B, Ning G. 2010. Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves’ disease. J Endocrinol Invest. 33:751–55.
   PubMed Web of Science ®Google Scholar